Beijing mabworks biotech · client: Everest medicines
Everest Medicines announced that it has entered into a commercialization license agreement with Beijing Mabworks Biotech Co., Ltd. under which the Company has obtained exclusive rights…
Company lists
Life sciences tech, oncology, genomics, neurology, startups and more: the companies building life sciences in New York City, New York, with their founders, funding, team size and business models.
Funding, M&A, contract wins and launches involving 857 life sciences companies in New York City, last 24 months: 78 M&A deals · 67 funding rounds · 13 Contracts · 4 launches. Newest first; companies and investors link to their Fliar profiles. Latest event in our news feed: Jun 2026.
Everest Medicines announced that it has entered into a commercialization license agreement with Beijing Mabworks Biotech Co., Ltd. under which the Company has obtained exclusive rights…
Waypoint Bio, an innovative biotechnology firm leveraging artificial intelligence to pioneer advanced CAR T-cell therapies for challenging solid tumors, has successfully closed a $20…
Dragos has acquired Phosphorus, broadening its reach across connected devices in operational environments.
Dragos enhances its xOT cybersecurity platform with the acquisition of Phosphorus, bolstering defense for critical infrastructure's connected devices.
Candid is choosing the M&A route instead, opting to accept a $2 billion buyout offer that gives UCB the biotech’s pipeline of T cell engagers for immune disorders.
Sowell Launches 'Family Office Lite,' Advisor Partnership Program Merchant has agrees to provide funding for future M&As to the RIA led by Bill Sowell.
Rocket Pharmaceuticals announced this week the sale of its rare pediatric disease priority review voucher (PRV) for $180 million.
Lucid Diagnostics on Thursday announced that it had priced an underwritten registered direct offering of 18,000,000 common shares at a purchase price of $1.00 per share for total…
Everest Medicines’ wholly owned subsidiary EverSea Medicines (Singapore) has signed a share purchase agreement to conditionally acquire Hasten Biopharmaceuticals, a subsidiary of Hasten…
Horizon Technology Finance Corporation announced it has provided a $40 million loan facility to Hyperfine, Inc., with an initial $15 million funded at closing and up to $25 million…
Protagenic Therapeutics, Inc. (OTCQB:PTIX), a clinical-stage biopharmaceutical company developing first-in-class treatments for stress-related neuropsychiatric disorders, today announced…
Deals included a $2.7 billion financing for cloud services platform Dropbox and $570 million for Axsome Therapeutics.
One of the standout healthtech deals was Esper Bionics, which secured $5 million in a round led by YZR Capital.
Pfizer’s fight with Novo Nordisk to buy obesity drug start-up Metsera
Epicured, a food-is-medicine meal delivery company originally focused on digestive health, has acquired Chiyo, a women’s nutrition company offering stage-specific meal programs spanning…
ILiAD Biotechnologies , a biotech based in FL, USA raised a $115 M Series B funding round.
Immunic, Inc. (Nasdaq: IMUX), a late‑stage biotechnology company pioneering the development of novel oral therapies for neurologic and gastrointestinal diseases, today announced the…
Apollo Biowellness, Inc. (OTCID: KOAN) (the "Company"), announces that the 'Exclusive Distribution Agreement' dated July 1, 2025, between Evolutionary Biologics (a wholly owned…
In fact, ... One example is healthtech company Thorne, which recently unveiled Taia, its AI-powered wellness advisor.
LB Pharmaceuticals Inc announced that it has entered into a securities purchase agreement to sell 3,306,571 shares of its common stock and pre-funded warrants to purchase up to 1,417,107…
Daxor Corporation (NasdaqCM: DXR) ("Daxor" or the "Company") announced today that it has entered into a definitive agreement with fundamental investors for the purchase and sale of an…
Lucid Diagnostics awarded U.S. Dept of Veterans Affairs contract for EsoGuard
Last year (2025), Sun Pharma acquired Checkpoint Therapeutics for a total deal value of $416 million, helping it access a range of advanced immunotherapies used for targeted treatment…
Carestream Health has completed a comprehensive restructuring and has formally split its business into two geographically oriented companies, and has sold its international medical…
Intelligent Bio Solutions (INBS) stock dove on Friday after the biotechnology company announced a private placement with institutional investors. This $10 million private placement…
In an anticipated move, Dassault Systèmes, a French enterprise IT firm (its better-known aviation business is a separate company) will acquire Medidata Solutions, at a 17% premium over…
On the surface, the acquisition by Veeva seems to be a lot of money for what it’s getting—the purchase price works out to about $2.4 million per Crossix employee (there’s also $120…
Tonix Pharmaceuticals (TNXP) entered into a securities purchase agreement with Point72 for the purchase and sale of 615,025 shares of its common stock at an offering price of $16.26 per…
Nanit has raised $50 million in a growth capital round led by Springcoast Partners, with participation from Upfront Ventures and JVP.
Sidley represented Immunovant, Inc., a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases, in its US$550 million underwritten…
Few life sciences companies in New York City, New York publish revenue, so this list compares what is on record instead: recorded equity funding, team size, revenue model, age and stage. The 50 companies below lead on recorded funding and team size among 605 active companies.

Provider of a digital platform for weight loss management and behavior change
Fitness & wellness techUS$623.85m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Mobile platforms for group-based wellness and health behavior support
CPC G16H20/60, H04L67/22, G16H40/20Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of AI-powered drug discovery platform for various diseases
Life sciences techUS$608.25m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

AI and cloud-based platforms provide data-driven insights to healthcare providers
Healthcare itUS$514.00m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Discovering novel therapeutics for neurological and metabolic diseases
Life sciences platforms and toolsUS$479.00m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: NK3 receptor modulators for treating neurological and metabolic disorders
CPC C07D471/04, A61P1/00, C07D498/10Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of medical affair services for biopharma and medical device industry
Life sciences techUS$320.86m across 5 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of drugs for the treatment of cancer
ImmunologyUS$313.00m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of closed-system transfer devices for handling drugs
Hospital equipmentEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutics for cancer treatment
OncologyFocus: Design and synthesis of heterocyclic small‑molecule cancer drugs targeting nuclear hormone receptors.
CPC C07D471/04, C07D487/04, A61P35/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of clinical research healthcare services
Life sciences techFocus: Secure digital credential issuance and verification for government, construction, and IoT devices.
CPC H04L63/123, B62M6/75, G06F21/45Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of gene therapy for the treatment of CLN2 Batten and Alzheimer's diseases
NeurologyUS$185.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutics for the treatment of rare neurological disorders
GenomicsUS$183.50m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Engineered protein therapeutics for T‑reg activation and optimized GALC enzyme replacement.
CPC C07K16/2866, C07K14/475Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developed of brain-computer interface tool for medical treatment and drug development
Brain computer interfaceUS$182.65m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of an automated platform for patients and clinics to manage frozen eggs and embryos
Women healthUS$176.91m across 5 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of immunity-inducing vaccine for the prevention and treatment of pertussis
Infectious diseasesUS$166.17m across 8 disclosed equity rounds
Darker bars = larger roundsFocus: Lyophilized live bacterial vaccine production and neuroprotective therapeutic formulations.
CPC A61K39/099, A61M3/0283, A61P25/28Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of drugs for neuropsychiatric conditions
NeurologyUS$151.55m across 10 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of dental aligners
Dental disordersUS$147.78m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Automated deployment and management of cloud infrastructure services
CPC G06Q10/0633, H04L41/145Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of medications to treat ophthalmic diseases
OphthalmologyUS$142.20m across 9 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of an AI models for protein design
Life sciences techEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of small molecule based therapeutics for schizophrenia
NeurologyUS$130.09m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Small-molecule immunomodulators targeting CXCR4/Btk, IL-6, and complement pathways
CPC A61K38/12, A61K31/4709, A61K38/08Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutics for the treatment of solid and liquid cancers
OncologyUS$128.15m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Cancer immunotherapy: GCN2 modulators, beta‑glucan/CD40 agonists, and novel crystalline drugs
CPC A61K31/716, A61K31/4985, C07D487/04Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of hemostatic products for wound care
Wound careUS$118.35m across 8 disclosed equity rounds
Darker bars = larger roundsFocus: Surgical hemostatic adhesive polymers and in‑situ cross‑linkable wound‑sealant scaffolds.
CPC A61L26/0052, A61L15/225, A61M5/30Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutics for cancer treatment
GenomicsUS$117.27m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of smart baby monitoring systems with sleep and breathing analysis
Sleep medicineUS$116.60m across 5 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Proton Beam Therapy. Treatment for different types of Cancerous and non-cancerous tumors through Proton Therapy.
OncologyUS$115.61m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutics to treat neurological diseases
NeurologyUS$114.00m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Manufacturer of drugs for treating inflammation
ImmunologyUS$108.52m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of workforce healthcare solutions
Disease self managementUS$107.87m across 7 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutics for rare neurological diseases
Rare diseasesUS$105.92m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in health & consumer products
CPC A61K31/437, A61K31/196, C12N15/113Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Brand of nutrition supplements
Food & beverage productsUS$104.80m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Portable solar-powered smart speakers and low-floor vehicle suspension technologies
CPC B60G7/02, H04R1/2857, H04R1/403Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapies targeting neural circuits for immune and inflammatory diseases
ImmunologyEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of precision medicine for the treatment of cancer
ImmunotherapyUS$97.50m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Therapeutic anti‑ERBB3 (HER3) monoclonal antibodies for NRG1‑fusion driven cancers
CPC C07K16/32, A61K39/39558Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutics for the treatment of Autism and other neurological diseases
NeurologyUS$95.96m across 13 disclosed equity rounds
Darker bars = larger roundsFocus: Neuropsychiatric disorder therapeutics and addiction treatment formulations
CPC A61K38/54, A61K38/4826, A61K38/465Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of CAR-T cell therapy for brain cancer and acute myeloid leukemia treatment
Cell therapyUS$95.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutics for cancer
OncologyEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of a platform for programmable protein interaction-based drug discovery
Life sciences techEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of small molecule therapeutics for cancer treatment
OncologyEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutics for invasive fungal infections
Infectious diseasesEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Online platform offering artificial intelligence-powered personalized grocery service
Online groceryUS$78.31m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: AI-powered grocery recommendation, recipe personalization, and automated packaging for perishable foods
CPC G06Q10/087, G06Q10/0833, G06Q30/0631Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of immunotherapeutics for the treatment of cancer
ImmunotherapyUS$72.30m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Repositioning Drugs in in injectable and ophthalmic space
OphthalmologyUS$71.09m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Digital remote health monitoring tool for providers
Life sciences techUS$70.65m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of medical devices for spine treatment and therapies
OrthopedicsUS$68.61m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer and manufactures of cellular health supplements
Nutraceuticals techUS$66.10m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Molten‑salt nuclear reactor power generation, including heat‑to‑electric conversion and salt‑based separation/corrosion mitigation
CPC B01D19/0031, G21C1/22, H02K7/1823Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of ambulatory ECG system with AI-enabled cardiac diagnostics
Healthcare itUS$66.14m across 14 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of novel therapeutics for the treatment of autoimmune, cancer, and other serious diseases
ImmunologyUS$64.82m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Electronic Data Capture (EDC), eCRF, ePRO application for online data collection for medical research
Life sciences techUS$63.25m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Innovative aesthetic devices maximizing practice potential with cutting-edge technology and treatment options
DermatologyEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of an AI platform for patient engagement in clinical trials
Healthcare itUS$55.75m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developing novel immunotherapy agents for cancer and inflammatory diseases
OncologyUS$54.93m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutics for cancer
GenomicsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
No matching company in this list.
This page shows the top 50. Radar has the complete, filterable list with contacts and live company signals.
Open life sciences in New York City on RadarFind top life sciences companies in New York City across drug discovery, oncology and genomics. Explore life sciences startups in New York City, research tools and clinical technology providers.
Technology platforms and tools supporting life sciences work.

Provider of AI-powered drug discovery platform for various diseases
Life sciences tech
Provider of clinical research healthcare services
Life sciences tech
Provider of an AI models for protein design
Life sciences tech
Developer of a platform for programmable protein interaction-based drug discovery
Life sciences tech
Electronic Data Capture (EDC), eCRF, ePRO application for online data collection for medical research
Life sciences techCompanies developing cancer therapies, diagnostics and treatment tools.

Developer of drugs for the treatment of cancer
Immunology
Developer of therapeutics for cancer treatment
Oncology
Developer of therapeutics for the treatment of solid and liquid cancers
Oncology
Proton Beam Therapy. Treatment for different types of Cancerous and non-cancerous tumors through Proton Therapy.
Oncology
Manufacturer of drugs for treating inflammation
ImmunologyBusinesses working on sequencing, genomics and genetic analysis.

Discovering novel therapeutics for neurological and metabolic diseases
Life sciences platforms and tools
Developer of therapeutics for the treatment of rare neurological disorders
Genomics
Developer of therapeutics for cancer treatment
Genomics
Developer of therapeutics for cancer
Genomics
Pioneering ovarian health therapeutics for women's unique biological needs
Women healthLife sciences companies focused on neurological and rare diseases.

Developer of gene therapy for the treatment of CLN2 Batten and Alzheimer's diseases
Neurology
Developer of therapeutics for the treatment of rare neurological disorders
Genomics
Developer of drugs for neuropsychiatric conditions
Neurology
Developer of small molecule based therapeutics for schizophrenia
Neurology
Developer of therapeutics to treat neurological diseases
NeurologyRecently founded life sciences companies in New York City.

Developed of brain-computer interface tool for medical treatment and drug development
Brain computer interface
Provider of an AI models for protein design
Life sciences tech
Developer of therapeutics to treat neurological diseases
Neurology
Developer of therapies targeting neural circuits for immune and inflammatory diseases
Immunology
Developer of therapeutics for invasive fungal infections
Infectious diseasesLife sciences employers with hiring activity in New York City.

Provider of AI-powered drug discovery platform for various diseases
Life sciences tech
AI and cloud-based platforms provide data-driven insights to healthcare providers
Healthcare it
Developer of therapeutics for cancer treatment
Oncology
Developer of gene therapy for the treatment of CLN2 Batten and Alzheimer's diseases
Neurology
Developer of therapeutics for the treatment of rare neurological disorders
GenomicsPublicly listed life sciences companies in New York City.

Developer of drugs for the treatment of cancer
Immunology
Developer of therapeutics for cancer treatment
Oncology
Developer of gene therapy for the treatment of CLN2 Batten and Alzheimer's diseases
Neurology
Developer of therapeutics for the treatment of rare neurological disorders
Genomics
Developer of small molecule based therapeutics for schizophrenia
NeurologyThe most-installed Android apps published by life sciences companies headquartered in New York City — 23.0M installs between them. 9 companies on this page publish at least one app; each company (legal entity) appears once, with its most-installed app.
The figures on this page come from Fliar’s company, funding, hiring and news data. Use it through the Investor Intelligence API and company data exports, or explore every company, founder and investor in Radar.
22,455 recorded equity rounds have gone to 27,407 life sciences companies in the United States — how much, at which stage, into which sub-sectors, from whom, and how New York City compares. Debt, IPO and grant rounds are excluded.
US$13.54bn
US$37.38bn
5,603 rounds in the United States
last 24 months
Bars show US$ raised; the number under each year is equity rounds. 2026 is year to date. The peak year was 2021, with US$45.29bn across 1383 rounds.
Equity rounds over the last five years, 857 life sciences companies in New York City among 27,407 in the United States.
Each deal appears in the events strip at the top of the page.
Go deeper in the life sciences landscape reports:
Life Sciences Industry Landscape of New York City Life Sciences Industry Landscape of the United States Accounting and Tax Software Industry Landscape of New York CityThe financials above are one chapter. The full life sciences landscape of New York City maps the whole industry — every segment, the capital behind it, the talent market and where the next opportunities are.
219 life sciences companies in New York City have recorded equity funding, US$9.92bn in total. Totals and round dates describe the historical record; they are not current valuations.
Largest recorded equity totals, with the latest recorded round.
Fitness & wellness techProvider of a digital platform for weight loss management and behavior change
Life sciences techProvider of AI-powered drug discovery platform for various diseases
Healthcare itAI and cloud-based platforms provide data-driven insights to healthcare providers
Life sciences platforms and toolsDiscovering novel therapeutics for neurological and metabolic diseases
Life sciences techProvider of medical affair services for biopharma and medical device industry
ImmunologyDeveloper of drugs for the treatment of cancer
Hospital equipmentDeveloper of closed-system transfer devices for handling drugs
OncologyDeveloper of therapeutics for cancer treatment
Life sciences techProvider of clinical research healthcare services
Founders
Details not available
NeurologyDeveloper of gene therapy for the treatment of CLN2 Batten and Alzheimer's diseases
GenomicsDeveloper of therapeutics for the treatment of rare neurological disorders
Brain computer interfaceDeveloped of brain-computer interface tool for medical treatment and drug development
Women healthProvider of an automated platform for patients and clinics to manage frozen eggs and embryos
Infectious diseasesDeveloper of immunity-inducing vaccine for the prevention and treatment of pertussis
NeurologyDeveloper of drugs for neuropsychiatric conditions
Dental disordersDeveloper of dental aligners
US$623.85m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Mobile platforms for group-based wellness and health behavior support
CPC G16H20/60, H04L67/22, G16H40/20Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$608.25m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$514.00m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$479.00m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: NK3 receptor modulators for treating neurological and metabolic disorders
CPC C07D471/04, A61P1/00, C07D498/10Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$320.86m across 5 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$313.00m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Design and synthesis of heterocyclic small‑molecule cancer drugs targeting nuclear hormone receptors.
CPC C07D471/04, C07D487/04, A61P35/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Secure digital credential issuance and verification for government, construction, and IoT devices.
CPC H04L63/123, B62M6/75, G06F21/45Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$185.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$183.50m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Engineered protein therapeutics for T‑reg activation and optimized GALC enzyme replacement.
CPC C07K16/2866, C07K14/475Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$182.65m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$176.91m across 5 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$166.17m across 8 disclosed equity rounds
Darker bars = larger roundsFocus: Lyophilized live bacterial vaccine production and neuroprotective therapeutic formulations.
CPC A61K39/099, A61M3/0283, A61P25/28Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$151.55m across 10 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$147.78m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Automated deployment and management of cloud infrastructure services
CPC G06Q10/0633, H04L41/145Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Meet the people behind life sciences companies in New York City. 456 of 605 companies list founders or leaders; where a public LinkedIn profile matches exactly, the expanded profile shows the photo, headline, location and education.
Companies whose recorded headcount rose the most between the two most recent team-size snapshots. A larger team is a signal of momentum, not of profitability.
OncologyDeveloping novel immunotherapy agents for cancer and inflammatory diseases
GastroenterologySupplements and reviews for HGH, male enhancement, and legal steroids
OncologyProton Beam Therapy. Treatment for different types of Cancerous and non-cancerous tumors through Proton Therapy.
Wearable technologyDeveloper of AI and cloud-based device for cardiac health monitoring and activity tracking
OncologyDeveloper of medical devices and biomarkers to detect various diseases
Life sciences techDeveloper of diagnostic tests for central nervous system and gastrointestinal disorders
Wearable technologyProvider of glucometer device and strips for diabetes management
OncologyDeveloper of therapeutics for cancer treatment
Life sciences techProvider of a platform for computational drug designing using AI
Founders
Details not available
Life sciences techDeveloper of platforms for the clinical trials industry which connects patients with clinical trials
Disease self managementDeveloper of fingerprint drug testing and sweat drug monitoring solutions
Life sciences techProvider of an AI accelerator for biomedical research and drug discovery
US$54.93m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$17.43m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$115.61m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$47.60m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Patents concentrated in health & consumer products
CPC A61B18/1492, A61M39/02, A61M25/04Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$47.65m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Molecular exposomics platforms and bio-surface topographic imaging for health monitoring
CPC G01B11/24, G01N33/6848, G16H10/20Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Design and synthesis of heterocyclic small‑molecule cancer drugs targeting nuclear hormone receptors.
CPC C07D471/04, C07D487/04, A61P35/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$21.49m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Life sciences companies in New York City with at least one woman on the founding team. Expand a profile to meet the founders; teams can include both women and men.
GenomicsProvider of next-generation gene-editing therapies

Dental disordersDeveloper of dental aligners
Online groceryInternet first restaurant offering plant-based ready-to-eat meals
Life sciences techProvider of AI-based clinical trial management tool
Food techInternet first restaurant delivering plant-based smoothies and meals
GenomicsCloud platform for personal genomics
Women healthPioneering ovarian health therapeutics for women's unique biological needs
Life sciences techProvider of home healthcare services
Founders
Details not available
Healthcare itDeveloper of an AI platform for patient engagement in clinical trials
NeurologyProvider of portable brain-stimulating device
Life sciences platforms and toolsParticle characterization solutions using Total Holographic Characterization for diverse applications
GenomicsProvider of pharmacogenomic solutions for cancer
US$3.75m across 2 disclosed equity rounds
Darker bars = larger rounds
Focus: Lipid nanoparticle delivery systems for tissue-specific CRISPR gene editing therapies.
CPC C12N15/11, C07D317/28, C12N15/1138Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$147.78m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Automated deployment and management of cloud infrastructure services
CPC G06Q10/0633, H04L41/145Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$23.59m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$14.13m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$15.26m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$15.82m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Integrated low‑pass whole‑genome and targeted DNA sequencing for comprehensive genomic analysis
CPC C12Q1/6874Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$24.89m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: FSH receptor modulators and peripheral melatonin agonist formulations for reproductive health
CPC C12Q1/6883, G16B40/00, G16H10/60Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$7.60m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$55.75m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$5.64m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$1.78m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Advanced holographic imaging for particle characterization and cell viability assays
CPC G01N15/0227, G01N15/1459, G01N15/08Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Life sciences companies in New York City founded in the last four years, newest first.
Dental disordersManufacturer of professional-grade teeth whitening agents for dentists and distributors
Founders
Details not available
Life sciences techAI-driven platform focused on drug discovery through biological simulation
ImmunologyDeveloper of gene therapy solutions designed for precision and safety
Life sciences techProvider of a platform for drug discovery for the treatment of cancer and rare diseases
Developer of therapies targeting autoimmune diseases using T-cell engager technology
Founders
Details not available
NeurologyDeveloper of therapies intended to transform mental health treatment options
Life sciences techAI based phenotypic drug discovery platform
Founders
Details not available
Cell therapyDeveloper of stem cell-based therapies for aging and disease prevention
GenomicsProvider of carbon capture solution
Infectious diseasesDeveloper of therapeutics for invasive fungal infections
ImmunologyDeveloper of therapies targeting neural circuits for immune and inflammatory diseases
Founders
Details not available
Sleep medicineDeveloper of novel therapies for chronic insomnia
Founders
Details not available
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$50.60m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Companies with the most distinct news events in the last 24 months across the business press Fliar tracks.
ImmunotherapyDeveloper of treatments for B-cell malignancies and autoimmune diseases
Infectious diseasesDeveloping novel antivirals to treat serious viral diseases

ImmunotherapyDeveloper of immunotherapeutics to treat cancer
NeurologyDeveloper of therapeutic solutions for the management of CNS disorders
Disease self managementDeveloper of fingerprint drug testing and sweat drug monitoring solutions
NeurologyDeveloper of next-generation medicines for CNS and immunological disorders
Infectious diseasesDeveloper of anti-infective therapeutics for bio-warfare threats
OncologySpeciality Pharmaceutical and medical device company focused on oncology
OncologyDeveloping novel immunotherapy agents for cancer and inflammatory diseases
GastroenterologyDeveloper of diagnostic kit for oesophagal cancer
ImmunologyDeveloper of oral immunology therapies for treating chronic inflammatory and autoimmune diseases
Founders
Details not available
Rare diseasesDeveloper of gene-modified cell therapies for the treatment of rare diseases
Focus: Patents concentrated in chemistry & materials
CPC C07H19/16, A61K31/5377, C07D487/14Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Focus: Antiviral heterocyclic small molecules and crystalline forms for herpes virus treatment
CPC C07D417/12, C07D403/08, C07D281/16Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$8.70m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in health & consumer products
CPC A61K31/5415, A61K31/137, A61K9/2009Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$4.45m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Antiviral small‑molecule synthesis and oral/IV formulation of Tecovirimat.
CPC C07D471/04, C07D209/56, A61K31/403Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$54.93m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
The most common specialisations among life sciences companies in New York City. Open a company to see what it sells, who runs it and how far it has come.
111 life sciences companies in New York City work in life sciences tech. Shown: the best-documented.
Life sciences techProvider of medical affair services for biopharma and medical device industry
Healthcare itAI and cloud-based platforms provide data-driven insights to healthcare providers
Life sciences techElectronic Data Capture (EDC), eCRF, ePRO application for online data collection for medical research
Life sciences techProvider of an AI based practice management software for clinic trials and clinics
Life sciences techCloud and AI-led analytics platform for drug discovery and development
Life sciences techDigital remote health monitoring tool for providers
Life sciences techProvider of AI-based clinical trial management tool
Life sciences techProvider of clinical research healthcare services
Founders
Details not available
Healthcare itProvider of automated natural language generation software for regulatory writing
Social platformsProvider of an AI-based patient engagement platform for healthcare providers and clinical trail researchers
Life sciences techProvider of cloud based platform for the development of algorithms
Life sciences techProvider of patient screening, recruitment, and analytics solution
US$320.86m across 5 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$514.00m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$63.25m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Clinical data integration and interactive health informatics platforms
CPC G16H70/40, G16H10/20Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$70.65m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$14.13m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Secure digital credential issuance and verification for government, construction, and IoT devices.
CPC H04L63/123, B62M6/75, G06F21/45Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$19.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$48.57m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$15.66m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: AI-driven patient identification and recruitment for clinical trial eligibility matching.
CPC G16H10/20Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
105 life sciences companies in New York City work in oncology. Shown: the best-documented.
ImmunologyDeveloper of drugs for the treatment of cancer
ImmunotherapyDeveloper of treatments for B-cell malignancies and autoimmune diseases
OncologyProton Beam Therapy. Treatment for different types of Cancerous and non-cancerous tumors through Proton Therapy.
OncologyDeveloping novel immunotherapy agents for cancer and inflammatory diseases
OncologyDeveloper of small molecule therapeutics for cancer treatment
OncologyDeveloper of medical devices and biomarkers to detect various diseases
Cell therapyDeveloper of CAR-T cell therapy for brain cancer and acute myeloid leukemia treatment
OncologyDeveloper of therapeutics for cancer treatment
OncologyDeveloper of therapeutics for the treatment of solid and liquid cancers
OncologyDeveloper of therapeutics for cancer
OncologyDeveloper of cell therapies and immunotherapies to treat cancer
OncologyProvider of immune based therapies for the treatment of cancer
US$313.00m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Patents concentrated in chemistry & materials
CPC C07H19/16, A61K31/5377, C07D487/14Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$115.61m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$54.93m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Patents concentrated in health & consumer products
CPC A61B18/1492, A61M39/02, A61M25/04Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$95.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Design and synthesis of heterocyclic small‑molecule cancer drugs targeting nuclear hormone receptors.
CPC C07D471/04, C07D487/04, A61P35/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$128.15m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Cancer immunotherapy: GCN2 modulators, beta‑glucan/CD40 agonists, and novel crystalline drugs
CPC A61K31/716, A61K31/4985, C07D487/04Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$8.12m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Engineered gamma‑delta T‑cell CAR immunotherapies and targeted peptide cancer treatments
CPC A61K33/243, A61P35/00, A61K40/405Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
89 life sciences companies in New York City work in genomics. Shown: the best-documented.
GenomicsProvider of next-generation gene-editing therapies

GenomicsProvider of COVID-19 testing platform

GenomicsProvider of health management platform for employers and insurers
OncologyDeveloper of medical devices and biomarkers to detect various diseases
Life sciences platforms and toolsDiscovering novel therapeutics for neurological and metabolic diseases
GenomicsDeveloper of therapeutics for the treatment of rare neurological disorders
GenomicsCloud platform for personal genomics
Women healthPioneering ovarian health therapeutics for women's unique biological needs
GenomicsDeveloper of therapeutics for cancer treatment
Developer of genetic test kits for health analysis
GenomicsProvider of pharmacogenomic solutions for cancer
GenomicsProvider of recombinant proteins for the treatment of gastrointestinal diseases
US$3.75m across 2 disclosed equity rounds
Darker bars = larger rounds
Focus: Lipid nanoparticle delivery systems for tissue-specific CRISPR gene editing therapies.
CPC C12N15/11, C07D317/28, C12N15/1138Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$13.10m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Patents concentrated in health & consumer products
CPC A61B18/1492, A61M39/02, A61M25/04Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$479.00m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: NK3 receptor modulators for treating neurological and metabolic disorders
CPC C07D471/04, A61P1/00, C07D498/10Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$183.50m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Engineered protein therapeutics for T‑reg activation and optimized GALC enzyme replacement.
CPC C07K16/2866, C07K14/475Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$15.82m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Integrated low‑pass whole‑genome and targeted DNA sequencing for comprehensive genomic analysis
CPC C12Q1/6874Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$24.89m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: FSH receptor modulators and peripheral melatonin agonist formulations for reproductive health
CPC C12Q1/6883, G16B40/00, G16H10/60Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$117.27m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$17.25m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: AI-driven polygenic risk scoring and disease risk prediction using machine learning
CPC G16B40/20, G16H50/30, G16B20/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$1.30m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
64 life sciences companies in New York City work in neurology. Shown: the best-documented.
NeurologyDeveloper of therapeutic solutions for the management of CNS disorders
NeurologyDeveloper of next-generation medicines for CNS and immunological disorders
NeurologyDeveloper of therapeutics for pain relief and inflammatory diseases
NeurologyDeveloper of gene therapy for the treatment of CLN2 Batten and Alzheimer's diseases
Rare diseasesDeveloper of therapeutics for rare neurological diseases
NeurologyDeveloper of therapeutics to treat neurological diseases
Brain computer interfaceDeveloped of brain-computer interface tool for medical treatment and drug development
NeurologyProvider of portable brain-stimulating device
Life sciences techDeveloper of diagnostic tests for central nervous system and gastrointestinal disorders
NeurologyEye tracking technology to detect traumatic brain injury (TBI)
NeurologyDeveloper of therapeutics for Alzheimer’s disease and related neurodegenerative diseases
NeurologyDeveloper of therapeutics for the treatment of Autism and other neurological diseases
US$8.70m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in health & consumer products
CPC A61K31/5415, A61K31/137, A61K9/2009Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$4.45m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$51.00m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Novel oral and oligosaccharide delivery systems for kappa opioid receptor agonist therapeutics
CPC C07K5/1016, C07D487/04, A61K38/07Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$185.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$105.92m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in health & consumer products
CPC A61K31/437, A61K31/196, C12N15/113Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$114.00m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$182.65m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$5.64m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$47.65m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Molecular exposomics platforms and bio-surface topographic imaging for health monitoring
CPC G01B11/24, G01N33/6848, G16H10/20Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$21.98m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Eye‑tracking based diagnostic systems for concussion, substance use, and glaucoma detection.
CPC A61B3/113, A61B3/16, A61B5/4064Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$7.90m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Small-molecule inhibitors targeting tau oligomer formation for neurodegenerative therapeutics
CPC C12N9/6424, C12N9/6421, C07D239/91Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$95.96m across 13 disclosed equity rounds
Darker bars = larger roundsFocus: Neuropsychiatric disorder therapeutics and addiction treatment formulations
CPC A61K38/54, A61K38/4826, A61K38/465Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
260 more company lists you can search, plus the Radar directory pages for each place.
No list matches. Try a shorter word.
We will reply with coverage, fields and pricing for your use case.
Filed revenue, profit and growth for every company on this page are available with a Radar account. Log in and you will come straight back here with all figures open.